Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
After the 2026 patent expiry, here's how doctors actually choose
All ADVBioLabs compounds are positioned for research and analytical workflows exclusively and are not approved by the Therapeutic Goods Administration (TGA) for any clinical use
As an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is not currently approved in the UK and remains available only within authorised clinical trials
This signals a major shift in the countrys diabetes and obesity care market
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
